<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02026622</url>
  </required_header>
  <id_info>
    <org_study_id>PHAO 2012 - TD / EMPHILINE</org_study_id>
    <nct_id>NCT02026622</nct_id>
  </id_info>
  <brief_title>Comparative Study of Physiological and Cerebrovascular Reactivity in Depression, at the Three Phases of Emotion</brief_title>
  <acronym>EMPHILINE</acronym>
  <official_title>Comparative Study of Physiological and Cerebrovascular Reactivity in Depression, at the Three Phases of Emotion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Tours</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Tours</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective is to compare the physiological reactivity (heart and respiratory rates,
      galvanic skin response, cerebral perfusion, and startle) in the three phases of emotion
      between depressive subjects, subjects remitted from depression and control subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">May 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>amplitude variations of heart and respiratory rate, cerebral pulsatility, galvanic skin response and startle as measure of physiological reactivity</measure>
    <time_frame>one day</time_frame>
    <description>amplitude variations of heart and respiratory rate, cerebral pulsatility, galvanic skin response and startle.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MRI data as measure of cerebral perfusion, volume of leukoaraiosis and default network (fMRI at rest)</measure>
    <time_frame>one day</time_frame>
    <description>cerebral perfusion measured by MRI (Arterial Spin Labelling) volume of leukoaraiosis default network (fMRI at rest)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ultrasound data of doppler as measure of cerebral pulstility</measure>
    <time_frame>one day</time_frame>
    <description>doppler index of middle cerebral artery At the same time, heart rate variability and cerebral pulsatility at rest will be collected</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>score of psychometric tests as measure of emotional state</measure>
    <time_frame>one day</time_frame>
    <description>MADRS score, ERD score, STAI-E score, anhedonia score, Neo-PI score, and the subjective assessment of emotional arousal (self Manikin assessment).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>spontaneous verbal production to emotional pictures and explicitative interviews</measure>
    <time_frame>one day</time_frame>
    <description>spontaneous verbal production to emotional pictures and explicitative interviews</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>3 groups of subjects</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>3 groups: depressive subjects, subjects remitted from depression and control subjects, with the same interventions.
psychometric tests, MRI, transcranial doppler and TPI, explicitative interview</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>psychometric tests</intervention_name>
    <description>NEO-PI, MADRS, MINI depression, MMSE, STAI-E, ERD, Anhedonia</description>
    <arm_group_label>3 groups of subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI</intervention_name>
    <description>ASL, rest f-MRI, FLAIR, white matter hyper intensities load</description>
    <arm_group_label>3 groups of subjects</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>transcranial doppler and TPI</intervention_name>
    <description>transcranial doppler TPI</description>
    <arm_group_label>3 groups of subjects</arm_group_label>
    <other_name>Tissue Pulsatility Imaging</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>explicitative interview</intervention_name>
    <arm_group_label>3 groups of subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female between 18 and 55

          -  Informed consent form signed

          -  Affiliated to a medical insurance

          -  visual and hearing abilities suitable for exams

          -  for the depressive group (group D): major depressive disorder according to the DSM-IV
             criteria as evaluated by the MINI test and MADRS score â‰¥22

          -  for the depressive patients in remission's group (group R) : matched on age, at least
             1 history of major depressive disorder in the last 10 years and solved for more than 6
             months, and MADRS score &lt; 9

          -  for the control subjects (group T) : matched on age, no psychiatric history, MADRS
             score &lt; 9

        Exclusion Criteria:

          -  psychotic disorder, bipolar disorder, addiction, suspected dementia (MMSE&lt;25)

          -  current betablockers or neuroleptics treatment

          -  any current organic unstable pathology

          -  history of serious cardiovascular disease (coronary syndrome, cardiac arrythmia, etc.)

          -  smoking &gt; 10 PY

          -  history of serious neurologic disease (stroke, cerebral tumour, serious cranial
             trauma, headache, ...)

          -  contra-indication to MRI

          -  uncorrected vision or audition troubles

          -  patient under juridic protection

          -  pregnancy, lactating or female without reliable contraception
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital of Tours</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2013</study_first_submitted>
  <study_first_submitted_qc>December 31, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 3, 2014</study_first_posted>
  <last_update_submitted>August 31, 2015</last_update_submitted>
  <last_update_submitted_qc>August 31, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>major depressive disorder</keyword>
  <keyword>cerebrovascular reactivity</keyword>
  <keyword>emotional reactivity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

